334 related articles for article (PubMed ID: 27848924)
1. Immunoanalytical characteristics of fecal calprotectin.
Desbène C; Gaillard O; Kapel N
Ann Biol Clin (Paris); 2016 Dec; 74(6):725-734. PubMed ID: 27848924
[TBL] [Abstract][Full Text] [Related]
2. [Fecal Calprotectin in Inflammatory Bowel Disease].
Lee J
Korean J Gastroenterol; 2016 May; 67(5):233-7. PubMed ID: 27206433
[TBL] [Abstract][Full Text] [Related]
3. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms.
Fagerberg UL; Lööf L; Myrdal U; Hansson LO; Finkel Y
J Pediatr Gastroenterol Nutr; 2005 Apr; 40(4):450-5. PubMed ID: 15795593
[TBL] [Abstract][Full Text] [Related]
4. Clinical importance of faecal calprotectin variability in inflammatory bowel disease: intra-individual variability and standardisation of sampling procedure.
Kristensen V; Malmstrøm GH; Skar V; Røseth A; Moum B
Scand J Gastroenterol; 2016; 51(5):548-55. PubMed ID: 26634305
[TBL] [Abstract][Full Text] [Related]
5. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
Kotze LM; Nisihara RM; Marion SB; Cavassani MF; Kotze PG
Arq Gastroenterol; 2015; 52(1):50-4. PubMed ID: 26017083
[TBL] [Abstract][Full Text] [Related]
6. Role of fecal calprotectin in the assessment of intestinal inflammation in children with familial Mediterranean fever.
Gucenmez OA; Kume T; Makay B; Babayigit O; Arslan N; Unsal E
Int J Rheum Dis; 2018 Oct; 21(10):1844-1848. PubMed ID: 30345692
[TBL] [Abstract][Full Text] [Related]
7. Fecal calprotectin in healthy term and preterm infants.
Nissen AC; van Gils CE; Menheere PP; Van den Neucker AM; van der Hoeven MA; Forget PP
J Pediatr Gastroenterol Nutr; 2004 Jan; 38(1):107-8. PubMed ID: 14676607
[No Abstract] [Full Text] [Related]
8. Interest of fecal calprotectine dosage in inflammatory bowel diseases, state of the art and perspectives.
Chaabouni T; Manceau H; Peoc'h K
Ann Biol Clin (Paris); 2016 Aug; 74(4):385-94. PubMed ID: 27492691
[TBL] [Abstract][Full Text] [Related]
9. Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.
Mooiweer E; Severs M; Schipper ME; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
J Crohns Colitis; 2015 Jan; 9(1):50-5. PubMed ID: 25518048
[TBL] [Abstract][Full Text] [Related]
10. The use of fecal calprotectin and lactoferrin in patients with IBD. Review.
Stragier E; Van Assche G
Acta Gastroenterol Belg; 2013 Sep; 76(3):322-8. PubMed ID: 24261027
[TBL] [Abstract][Full Text] [Related]
11. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease.
Bunn SK; Bisset WM; Main MJ; Gray ES; Olson S; Golden BE
J Pediatr Gastroenterol Nutr; 2001 Jul; 33(1):14-22. PubMed ID: 11479402
[TBL] [Abstract][Full Text] [Related]
12. Fecal calprotectin as a promising marker of inflammatory diseases.
Paduchova Z; Durackova Z
Bratisl Lek Listy; 2009; 110(10):598-602. PubMed ID: 20017448
[TBL] [Abstract][Full Text] [Related]
13. Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome.
Sydora MJ; Sydora BC; Fedorak RN
J Crohns Colitis; 2012 Mar; 6(2):207-14. PubMed ID: 22325175
[TBL] [Abstract][Full Text] [Related]
14. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
[TBL] [Abstract][Full Text] [Related]
15. The value of fecal calprotectin as a marker of intestinal inflammation in patients with ulcerative colitis.
Önal İK; Beyazit Y; Şener B; Savuk B; Özer Etık D; Sayilir A; Öztaş E; Torun S; Özderın Özın Y; Tunç Demırel B; Ülker A; Dağli Ü
Turk J Gastroenterol; 2012; 23(5):509-14. PubMed ID: 23161295
[TBL] [Abstract][Full Text] [Related]
16. Faecal calprotectin: a marker of inflammation throughout the intestinal tract.
Summerton CB; Longlands MG; Wiener K; Shreeve DR
Eur J Gastroenterol Hepatol; 2002 Aug; 14(8):841-5. PubMed ID: 12172403
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of calprotectin in irritable bowel syndrome and in inflammatory bowel disease.
Grad C; David L; Portincasa P; Dumitraşcu DL
Rom J Intern Med; 2012; 50(1):3-6. PubMed ID: 22788087
[TBL] [Abstract][Full Text] [Related]
18. Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease.
Mirsepasi-Lauridsen HC; Bachmann Holmetoft U; Ingdam Halkjær S; Angeliki Krogfelt K; Munk Petersen A
Scand J Gastroenterol; 2016; 51(2):211-7. PubMed ID: 26359672
[TBL] [Abstract][Full Text] [Related]
19. Fecal calprotectin in inflammatory bowel diseases: update and perspectives.
Manceau H; Chicha-Cattoir V; Puy H; Peoc'h K
Clin Chem Lab Med; 2017 Mar; 55(4):474-483. PubMed ID: 27658156
[TBL] [Abstract][Full Text] [Related]
20. Fecal Calprotectin as a Screening Marker for Inflammatory Bowel Disease.
Sridhar M; Kesavelu D
Indian Pediatr; 2019 Mar; 56(3):249-250. PubMed ID: 30955002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
